Chemstruc (Chemstruc)
Balsalazide Disodium Capsule
Product Images NDC 80005-126
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Balsalazide Disodium (NDC 80005-126). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Carnegie Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Containerlabel (Containerlabel)
Each capsule contains 750 mg of balsalazide disodium. The usual dosage information can be found in the package insert for full prescribing details. This package is child-resistant and should be kept out of reach of children. It is recommended to store the capsules between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F) as per USP Controlled Room Temperature guidelines. The capsules are manufactured by Carnegie Pharmaceuticals LLC in Delran, NJ 08075, USA. This product is Rx-only and consists of 280 capsules. Made in the USA. Revision date: 03/2024. NDC 80005-126-25.*
Figure1 (Figure1)
This text seems to be related to a medical evaluation of the improvement in patients by percentage, based on factors such as stool blood, stool frequency, and sigmoidoscopy results after treatment with two different dosages of Balsalazide Disodium. The dosages mentioned are 2.25 g (0.8 g mesalamine equivalents) and 6.75 g (2.4 g mesalamine equivalents) of Balsalazide Disodium.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
